Pharma Journalist -

Cidara Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to its investigational drug CD388 for the prevention of…
Read More...

Boehringer Ingelheim has received approval from the U.S. Food and Drug Administration (FDA) for its new oral therapy, JASCAYD (nerandomilast), for the treatment of idiopathic pulmonary…
Read More...

Turbine, a biotechnology company specializing in AI-based virtual disease modeling, has announced a collaboration with AstraZeneca to enhance the discovery of antibody-drug conjugates…
Read More...

Boston, MA | October 9, 2025 - Following the success of the inaugural LEAN Cell & Gene Summit in Boston, the event series is set to continue in National Harbor, Maryland, on…
Read More...

Werewolf Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its lead candidate WTX-124, a conditionally activated…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals' Libtayo® (cemiplimab-rwlc) as the first adjuvant immunotherapy for adult patients with cutaneous…
Read More...

Arthrosi Therapeutics, Inc., a late-stage biotechnology company focused on developing next-generation treatments for gout and tophaceous gout, has announced the successful closing of a…
Read More...

Algen Biotechnologies has entered a multi-target partnership with AstraZeneca aimed at speeding up the discovery of new therapeutic targets in immunology. The collaboration will…
Read More...

Milan-based biotech firm NanoPhoria Bioscience has announced the successful first close of its €83.5 million Series A funding round, marking a major step forward in its mission to…
Read More...

Oragenics, a clinical-stage biotech company focused on brain-targeted therapeutics, has announced a strategic collaboration with Receptor.AI, a drug profiling company leveraging…
Read More...